Canton Strategic Holdings (CNTN) Short term Debt (2020 - 2025)
Canton Strategic Holdings (CNTN) reported Short term Debt of $34376.0 for Q3 2025, down 57.44% on a YoY basis from $80768.0 in Q3 2024, and down 59.34% quarter-over-quarter from $84540.0 in Q2 2025.
Canton Strategic Holdings (CNTN) Short term Debt (2020 - 2025) Analysis & Trends
Canton Strategic Holdings has reported Short term Debt for 6 years, with the latest figure at $34376.0 in Q3 2025.
- For the quarter ending Q3 2025, Short term Debt fell 57.44% year-over-year to $34376.0; the trailing twelve-month figure through Sep 2025 stood at $34376.0 (down 57.44% YoY), and the FY2021 full-year result was $200000.0, changed 0.0% from the prior year.
- Short term Debt for Q3 2025 stood at $34376.0, down from $84540.0 in the prior quarter.
- The five-year high for Short term Debt was $559917.0 in Q1 2023, with the low at $34376.0 in Q3 2025.
- Historically, Short term Debt has averaged $211677.5 across 5 years, with a median of $200000.0 in 2021.
- Annual changes were most pronounced in 2023 — Short term Debt surged 179.96% — and 2025, when it plunged 57.74%.
- Canton Strategic Holdings' Short term Debt stood at $200000.0 in 2021, then changed by 0.0% to $200000.0 in 2022, then sank by 59.48% to $81040.0 in 2023, then fell by 0.34% to $80768.0 in 2024, then tumbled by 57.44% to $34376.0 in 2025.
- The last three Short term Debt figures came in at $34376.0 (Q3 2025), $84540.0 (Q2 2025), and $248599.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 34,376.00 |
| Jun 30, 2025 | 84,540.00 |
| Mar 31, 2025 | 248,599.00 |
| Sep 30, 2024 | 80,768.00 |
| Jun 30, 2024 | 200,048.00 |
| Mar 31, 2024 | 317,119.00 |
| Sep 30, 2023 | 81,040.00 |
| Jun 30, 2023 | 322,046.00 |
| Mar 31, 2023 | 559,917.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |